Advances in Pediatric Food Allergy: From Prevention to Treatment and Everything in Between

Saturday, December 5, 2020, 10:00 AM - 3:00 PM EST, Online


This is a half-day virtual course that will provide allergists, generalists, and allied health, with a comprehensive program on everything related to food allergies, from food allergy prevention, emerging diagnostic tools, new treatment options, to advice on counseling patients and their families on managing allergies outside of their home. Material presented will be based on scientific advances from the last year that support current clinical practice guidelines for food allergy.

1. Discuss how to accurately diagnose food allergy to reduce unnecessary dietary avoidances.
2. Recognize symptoms of anaphylaxis so that treatment can be administered promptly to improve patient outcomes.
3. Describe the first FDA-approved peanut allergy treatment and other emerging treatments for food allergy.
4. Identify nutritional issues that may result in food allergic individuals to ensure optimal growth and development occurs.
5. Explain how to manage food allergy in restaurants and school to help decrease allergic reactions outside of the home.
6. Describe current approaches to preventing food allergies based on recently published data.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (4.50 hours), Non-Physician Attendance (4.50 hours)

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Saturday, December 5, 2020